Cargando…
Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea
PURPOSE: The introduction of immune checkpoint inhibitors represents a major advance in the treatment of lung cancer, allowing sustained recovery in a significant proportion of patients. Nivolumab is a monoclonal anti–programmed death cell protein 1 antibody licensed for the treatment of locally adv...
Autores principales: | Lim, Sun Min, Kim, Sang-We, Cho, Byoung Chul, Kang, Jin Hyung, Ahn, Myung-Ju, Kim, Dong-Wan, Kim, Young-Chul, Lee, Jin Soo, Lee, Jong-Seok, Lee, Sung Yong, Park, Keon Uk, An, Ho Jung, Cho, Eun Kyung, Jang, Tae Won, Kim, Bong-Seog, Kim, Joo-Hang, Lee, Sung Sook, Na, Im-II, Yoo, Seung Soo, Lee, Ki Hyeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577826/ https://www.ncbi.nlm.nih.gov/pubmed/32599984 http://dx.doi.org/10.4143/crt.2020.245 |
Ejemplares similares
-
Decreasing incidence of Plasmodium vivax in the Republic of Korea during 2010–2012
por: Kim, Tong-Soo, et al.
Publicado: (2013) -
A Case of Intrapericardial Extralobar Pulmonary Sequestration: First Case in Korea
por: Ahn, Chul Min, et al.
Publicado: (1991) -
A randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated patients with advanced non–small cell lung cancer with EGFR mutation
por: Lee, Youngjoo, et al.
Publicado: (2022) -
High-dose Versus Low-dose Cyclophosphamide in Combination with G-CSF for Peripheral Blood Progenitor Cell Mobilization
por: Ahn, Jin Seok, et al.
Publicado: (2005) -
Association of Abdominal Obesity with Atherosclerosis in Type 2 Diabetes Mellitus (T2DM) in Korea
por: Cho, Minho, et al.
Publicado: (2008)